OSCR

Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis.

Overview

Authors: Fei He1, Shunjie Bai2, Jing Xie3, Yongzhi Zhang1, Ke Xu4,5, Jiaolin Wang1, Yi Ren4,5, Zhe Ren4,5, Jianjun Chen1, Ying Wang6, Peng Xie4,5
  1. Institute of Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China
  2. Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  3. Chongqing Key Laboratory of Emergency Medicine, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing, China
  4. Department of Neurology, National Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  5. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  6. Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
Journal: Frontiers in pharmacology, volume 17, article 1790866
Dates: received 19 January 2026; accepted 9 March 2026; published online 1 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fphar.2026.1790866 · PMID 41993570 · PMCID PMC13080252 · OpenAlex W7147834535
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), depression (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity, Smoothing, state filtering, decompositions
Keywords: Akkermansia muciniphila, depression, glycerophospholipid, inflammation, lipids
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: National Natural Science Foundation of China (CSTB2025NSCQ-GPX1158, CSTB2025NSCQ)
Citations: not cited yet (Europe PMC); 66 references in the paper

Abstract

Background: Akkermansia muciniphila (AKK) is a potential probiotic. Our previous studies have shown that it could alleviate depressive-like behaviors (DLBs) in mice by inhibiting neuroinflammation in brain. To further explore its antidepressant effect, this study focused on the effects of AKK on the metabolic activities in gut-brain axis.

Methods: After chronic restraint stress (CRS) depression model was successfully built, AKK was used as intervention method for 3 weeks. The gut microbiome in feces and two intestinal permeability proteins in colon (Claudin-1, Occludin) were measured, and the metabolites in feces, colon, liver, and prefrontal cortex were also measured. In addition, two inflammation-related factors in hippocampus (Free fatty acid receptors 3 (FFAR3), phosphorylated NF-κB p65 (p-p65)) were measured.

Results: AKK was successfully colonized in gut of chronic restraint stress (CRS) mice. The DLBs in CRS mice receiving AKK (CRS + AKK) were significantly improved, along with the improved gut microbiome. Both Claudin-1 and Occludin in colon were significantly increased in CRS + AKK mice compared to CRS mice receiving phosphate buffer saline (PBS) (CRS + p). Metabolomics analysis indicated that AKK could significantly improve the changed lipids and lipid-like molecules in gut-brain axis of CRS mice; and function analysis using differential metabolites showed that AKK could significantly improve the disordered glycerophospholipid metabolism in feces, colon, liver, and prefrontal cortex of CRS mice. Additionally, we found that FFAR3 and phosphorylated NF-κB p65 were increased and decreased, respectively, in hippocampus of CRS + AKK mice compared to CRS + p mice.

Conclusion: Our results suggested that AKK might improve the disturbances of gut microbiome, intestinal permeability, host’s lipid metabolism and inflammation levels in hippocampus. Glycerophospholipid metabolism in gut-brain axis might be the important mediator in the process of AKK producing antidepressants effects.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability statement

The datasets generated during the current study were available in online repositories. The names of the repository/repositories and accession number(s) can be found below: http://www.ncbi.nlm.nih.gov/bioproject/1400281.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added Natural Science Foundation of Chongqing: CSTB2025NSCQ-GPX1158, CSTB2025NSCQ

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 11 authors, 5 keywords, 66 references.

Cite

This paper

He, F., Bai, S., Xie, J., Zhang, Y., Xu, K., Wang, J., Ren, Y., Ren, Z., Chen, J., Wang, Y., & Xie, P. (2026). Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis. Frontiers in pharmacology, 17, 1790866. https://doi.org/10.3389/fphar.2026.1790866

BibTeX

@article{he2026akkermansia,
author = {He, Fei and Bai, Shunjie and Xie, Jing and Zhang, Yongzhi and Xu, Ke and Wang, Jiaolin and Ren, Yi and Ren, Zhe and Chen, Jianjun and Wang, Ying and Xie, Peng},
title = {{Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis}},
journal = {Frontiers in pharmacology},
year = {2026},
month = apr,
volume = {17},
pages = {1790866},
publisher = {Frontiers Media SA},
issn = {1663-9812},
doi = {10.3389/fphar.2026.1790866},
url = {https://doi.org/10.3389/fphar.2026.1790866},
pmid = {41993570},
pmcid = {PMC13080252}
}

RIS

TY - JOUR
AU - He, Fei
AU - Bai, Shunjie
AU - Xie, Jing
AU - Zhang, Yongzhi
AU - Xu, Ke
AU - Wang, Jiaolin
AU - Ren, Yi
AU - Ren, Zhe
AU - Chen, Jianjun
AU - Wang, Ying
AU - Xie, Peng
TI - Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis
T2 - Frontiers in pharmacology
J2 - Front Pharmacol
PY - 2026
DA - 2026/04/01
VL - 17
SP - 1790866
SN - 1663-9812
PB - Frontiers Media SA
DO - 10.3389/fphar.2026.1790866
UR - https://doi.org/10.3389/fphar.2026.1790866
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fphar.2026.1790866",
"type": "article-journal",
"title": "Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis",
"container-title": "Frontiers in pharmacology",
"author": [
{
"family": "He",
"given": "Fei"
},
{
"family": "Bai",
"given": "Shunjie"
},
{
"family": "Xie",
"given": "Jing"
},
{
"family": "Zhang",
"given": "Yongzhi"
},
{
"family": "Xu",
"given": "Ke"
},
{
"family": "Wang",
"given": "Jiaolin"
},
{
"family": "Ren",
"given": "Yi"
},
{
"family": "Ren",
"given": "Zhe"
},
{
"family": "Chen",
"given": "Jianjun"
},
{
"family": "Wang",
"given": "Ying"
},
{
"family": "Xie",
"given": "Peng"
}
],
"container-title-short": "Front Pharmacol",
"volume": "17",
"page": "1790866",
"DOI": "10.3389/fphar.2026.1790866",
"PMID": "41993570",
"PMCID": "PMC13080252",
"ISSN": "1663-9812",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fphar.2026.1790866",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1136/gpsych-2023-101374
Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications.
Journal: General psychiatry
In common: depression, 6 references
[2] doi:10.1186/s12866-025-04181-3
Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism.
Journal: BMC microbiology
In common: depression, mouse, 4 references
[3] doi:10.3389/fcimb.2023.1121445
Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice.
Journal: Frontiers in cellular and infection microbiology
In common: depression, mouse, 4 references
[4] doi:10.1186/s12916-026-04787-y
A human-derived Bacteroides strain attenuates depressive-like behavior in a rat model of social defeat-induced stress.
Journal: BMC medicine
In common: depression, 5 references
[5] doi:10.1186/s13041-024-01146-x
Chronic corticosterone exposure causes anxiety- and depression-related behaviors with altered gut microbial and brain metabolomic profiles in adult male C57BL/6J mice.
Journal: Molecular brain
In common: depression, mouse, 4 references
[6] doi:10.1016/j.ynstr.2022.100430
Changes in the rodent gut microbiome following chronic restraint stress and low-intensity rTMS.
Journal: Neurobiology of stress
In common: depression, 4 references
[7] doi:10.1021/acschemneuro.3c00127
Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders.
Journal: ACS chemical neuroscience
In common: 5 references
[8] doi:10.1080/19490976.2023.2281360 [code]
Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome.
Journal: Gut microbes
In common: depression, 4 references
[9] doi:10.1016/j.xcrm.2024.101798
Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation.
Journal: Cell reports. Medicine
In common: depression, mouse, cellular / molecular, 3 references
[10] doi:10.1080/19490976.2025.2492377
Multi-species probiotic supplement enhances vagal nerve function - results of a randomized controlled trial in patients with depression and healthy controls.
Journal: Gut microbes
In common: depression, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.